Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

As a leading cause of infant death, sudden infant death syndrome (SIDS) remains a perplexing diagnosis with no clear ...

BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ ...

BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting ...

BACKGROUND: Pathological cardiac remodeling after myocardial infarction (MI) is a leading cause of heart failure and sudden death. The detailed mechanisms underlying the transition to heart failure ...

BACKGROUND: Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality and are associated with acute cardiac events in the peripartum period, as well as ...

In patients with post-thrombotic syndrome, stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes. The risk of stent thrombosis ...

Cardiac catheterization is a test during which flexible tubes called catheters are inserted into the heart via an artery or vein under x-ray guidance to diagnose and sometimes treat certain heart ...

Studying trends in mortality is essential to advance understanding of population health. Further evaluation of long‐term heart disease mortality trends and subtypes in the United States is needed to ...

Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and ...

There is variability in how heart failure with preserved ejection fraction (HFpEF) is defined across societal guidelines and pivotal clinical trial inclusion criteria. 1 The recent emergence of ...